Geulah Livshits
Stock Analyst at Chardan Capital
(1.88)
# 3,067
Out of 4,749 analysts
173
Total ratings
26.67%
Success rate
-5.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRGX CARGO Therapeutics | Downgrades: Neutral | n/a | $3.60 | - | 3 | Jan 30, 2025 | |
| IMRX Immuneering | Maintains: Buy | $13 | $1.94 | +570.10% | 9 | Jan 8, 2025 | |
| KRYS Krystal Biotech | Maintains: Buy | $212 | $159.74 | +32.72% | 8 | Dec 18, 2024 | |
| TNYA Tenaya Therapeutics | Maintains: Buy | $18 | $1.06 | +1,598.11% | 9 | Dec 18, 2024 | |
| EDIT Editas Medicine | Downgrades: Neutral | n/a | $1.31 | - | 10 | Dec 13, 2024 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $94 | $41.59 | +126.02% | 11 | Dec 10, 2024 | |
| SNTI Senti Biosciences | Maintains: Buy | $10 → $12 | $4.36 | +175.23% | 7 | Dec 4, 2024 | |
| MGX Metagenomi | Maintains: Buy | $15 | $2.69 | +457.62% | 5 | Nov 20, 2024 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $62 | $10.74 | +477.28% | 14 | Nov 18, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $88 → $91 | $10.32 | +781.78% | 12 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $0.58 | +1,098.63% | 3 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $1.50 | +366.67% | 11 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $39 | $5.60 | +596.43% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $15 | $2.80 | +435.71% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $5.43 | +360.41% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $3.18 | +371.70% | 4 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $11 | $0.82 | +1,240.32% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $1.13 | +430.97% | 5 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $5.85 | +481.20% | 10 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $6.29 | +551.83% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $5.47 | +357.04% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.39 | +402.09% | 4 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $191 → $208 | $39.42 | +427.65% | 7 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $1.64 | +875.61% | 4 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $2.5 | $7.77 | -67.82% | 5 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $8.07 | +1,015.24% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $4 | $5.45 | -26.61% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $1.58 | +1,798.73% | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $30 | $4.22 | +610.90% | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $11.03 | +63.19% | 1 | Oct 27, 2020 |
CARGO Therapeutics
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.60
Upside: -
Immuneering
Jan 8, 2025
Maintains: Buy
Price Target: $13
Current: $1.94
Upside: +570.10%
Krystal Biotech
Dec 18, 2024
Maintains: Buy
Price Target: $212
Current: $159.74
Upside: +32.72%
Tenaya Therapeutics
Dec 18, 2024
Maintains: Buy
Price Target: $18
Current: $1.06
Upside: +1,598.11%
Editas Medicine
Dec 13, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.31
Upside: -
CRISPR Therapeutics AG
Dec 10, 2024
Maintains: Buy
Price Target: $94
Current: $41.59
Upside: +126.02%
Senti Biosciences
Dec 4, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $4.36
Upside: +175.23%
Metagenomi
Nov 20, 2024
Maintains: Buy
Price Target: $15
Current: $2.69
Upside: +457.62%
Rocket Pharmaceuticals
Nov 18, 2024
Maintains: Buy
Price Target: $62
Current: $10.74
Upside: +477.28%
Intellia Therapeutics
Nov 18, 2024
Maintains: Buy
Price Target: $88 → $91
Current: $10.32
Upside: +781.78%
Nov 14, 2024
Maintains: Buy
Price Target: $7
Current: $0.58
Upside: +1,098.63%
Nov 14, 2024
Maintains: Buy
Price Target: $7
Current: $1.50
Upside: +366.67%
Nov 14, 2024
Maintains: Buy
Price Target: $39
Current: $5.60
Upside: +596.43%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $2.80
Upside: +435.71%
Nov 13, 2024
Maintains: Buy
Price Target: $23 → $25
Current: $5.43
Upside: +360.41%
Nov 11, 2024
Maintains: Buy
Price Target: $15
Current: $3.18
Upside: +371.70%
Nov 7, 2024
Maintains: Buy
Price Target: $17 → $11
Current: $0.82
Upside: +1,240.32%
Apr 5, 2024
Maintains: Buy
Price Target: $11 → $6
Current: $1.13
Upside: +430.97%
Feb 20, 2024
Maintains: Buy
Price Target: $29 → $34
Current: $5.85
Upside: +481.20%
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $6.29
Upside: +551.83%
Mar 23, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $5.47
Upside: +357.04%
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $2.39
Upside: +402.09%
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $39.42
Upside: +427.65%
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $1.64
Upside: +875.61%
Aug 22, 2022
Maintains: Buy
Price Target: $4 → $2.5
Current: $7.77
Upside: -67.82%
Nov 3, 2021
Maintains: Buy
Price Target: $100 → $90
Current: $8.07
Upside: +1,015.24%
Nov 3, 2021
Maintains: Neutral
Price Target: $5.5 → $4
Current: $5.45
Upside: -26.61%
Aug 13, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $1.58
Upside: +1,798.73%
Jul 23, 2021
Maintains: Neutral
Price Target: $50 → $30
Current: $4.22
Upside: +610.90%
Oct 27, 2020
Initiates: Buy
Price Target: $18
Current: $11.03
Upside: +63.19%